Quick Answer
ADMA BIOLOGICS, INC. reported Stockholders Equity of $477.32 million for fiscal year 2025.
ADMA BIOLOGICS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $477.32M | +36.8% |
| 2024 | $349.02M | +158.1% |
| 2023 | $135.21M | -11.0% |
| 2022 | $151.97M | +7.7% |
| 2021 | $141.17M | +60.0% |
| 2020 | $88.25M | +236.9% |
| 2019 | $26.19M | +32.5% |
| 2018 | $19.77M | -51.0% |
| 2017 | $40.33M | +1004.9% |
| 2016 | -$4.46M | -642.9% |
| 2015 | $821.0K | -86.3% |
| 2014 | $6.01M | -72.1% |
| 2013 | $21.57M | +128.9% |
| 2012 | $9.42M | +2342.5% |
| 2011 | $385.8K | +109.8% |
| 2010 | -$3.93M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $431.19M | +85.9% | +8.2% |
| June 30, 2025 | $398.32M | +111.6% | +6.7% |
| March 31, 2025 | $373.42M | +142.9% | +7.0% |
| December 31, 2024 | $349.02M | +158.1% | +50.5% |
| September 30, 2024 | $231.89M | +53.1% | +23.2% |
| June 30, 2024 | $188.27M | +28.3% | +22.5% |
| March 31, 2024 | $153.71M | +5.5% | +13.7% |
| December 31, 2023 | $135.21M | -11.0% | -10.7% |
- ADMA BIOLOGICS, INC. showed an increase of +36.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2010–2025 period, ADMA BIOLOGICS, INC.’s stockholders equity has grown by 12255.8% (from -$3.93 million to $477.32 million).
- The most recent figure is from ADMA BIOLOGICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: